WeTrials

A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Intravenous Zotatifin (eFT226) in Subjects With Selected Advanced Solid Tumor Malignancies

What is this study?

This study is testing an investigational drug called Zotatifin for adults with advanced solid tumors. Researchers want to find the safest and most effective dose to help shrink or control cancer growth.

Who can participate?

Adults with certain types of advanced solid tumors who have already tried standard treatments may be eligible to join. The study team will review your specific medical history to see if it is a good fit for you.

What will happen?

Participants will receive the study medication intravenously, which means it is given directly into a vein. Your health and how your body responds to the treatment will be closely monitored by the medical team throughout the study.

Where and when?

The study is currently active with locations in places like Los Angeles and Newport Beach, California. More location details and enrollment steps can be provided by the study coordinators.

Key Points
  • 1Tests the safety and effects of the drug Zotatifin.
  • 2Designed for adults with advanced solid tumors.
  • 3Takes place at medical centers in California.

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Solid Tumor, Adult

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.